Clinical Trial Signals · weekly

Newly posted recruiting studies with US sites, every week.

Studies first posted on ClinicalTrials.gov in the past week that are recruiting now, grouped by state and lead sponsor, with the site, phase, conditions and a link to each record.

Subscribe — $149/mo See a sample week

Free one-week sample by reply. Email hello@enrollfeed.com with the states and therapy areas you cover.

Newly posted recruiting studies, Nov 13–20EnrollFeed · Mon 8:00 AM ET
Sample
  • Minnesota
  • Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesPhase 2Aclaris Therapeutics, Inc. · New Brighton
  • Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryPhase 2HealthPartners Institute · Saint Paul
  • Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 TrialPhase 3Mayo Clinic · Albert Lea
  • Florida
  • Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution After PTCyPhase 1H. Lee Moffitt Cancer Center and Research Institute · Tampa
ClinicalTrials.gov public records; no personal contact data

What's newly recruiting, sorted the way you staff it.

  1. Only what's new

    Studies first posted in the past week that are recruiting now and have at least one US recruiting site.

  2. By state, then sponsor

    Each recruiting site sits under its state and lead sponsor, with facility, city, phase and conditions.

  3. From the public record

    Source: ClinicalTrials.gov. We show the registry's data timestamp and our processing date. No names, phones or emails from study records.

This week's list, shortened

Nov 13–20: 39 newly posted recruiting studies, 51 US recruiting sites across 24 states, 38 lead sponsors. Below are real rows from that build.

Newly posted recruiting studies, Nov 13–20 Sample · real rows
Window
First posted Nov 13–20, 2026
Delivery
Every Monday by 8am ET by default, or a weekday you choose
Source
ClinicalTrials.gov public records; no personal contact data
Newly posted recruiting studies with US sites, Nov 13–20, 2026 (sample of real rows)
StudyPhaseConditionsRecruiting siteFirst postedSite status
Minnesota6 sites
Aclaris Therapeutics, Inc.
Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesNCT07935590Phase 2Lichen PlanusAclaris Clinical SiteNew BrightonNov 13Recruiting
HealthPartners Institute
Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryNCT07935278Phase 2Concussion (Diagnosis), Mild Traumatic Brain InjuryHealthPartners Neuroscience CenterSaint PaulNov 13Recruiting
Mayo Clinic
Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 TrialNCT07935889Phase 3Glioblastoma, IDH-WildtypeMayo Clinic Health System in Albert LeaAlbert LeaNov 13Recruiting
Mayo Clinic Health Systems-MankatoMankatoNov 13Recruiting
Mayo Clinic Radiation Therapy - NorthfieldNorthfieldNov 13Recruiting
Mayo Clinic in RochesterRochesterNov 13Recruiting
Florida5 sites
H. Lee Moffitt Cancer Center and Research Institute
Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution After PTCyNCT07940738Phase 1Hematologic MalignancyMoffitt Cancer CenterTampaNov 17Recruiting
RAI Services Company
Vuse Pro Puffing Topography Study in Adult SmokersNCT07938320Not applicableSmoking, TobaccoWACDoralNov 16Recruiting
L&E Research TampaTampaNov 16Recruiting
Trevi Therapeutics
A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy ParticipantsNCT07946575Phase 1Healthy ParticipantsClinical Pharmacology of Miami, LLCMiamiNov 18Recruiting
University of Florida
RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors - High Grade GliomaNCT07949071Phase 1, Phase 2Recurrent High-grade GliomaUF HealthGainesvilleNov 19Recruiting
Texas5 sites
Carnegie Mellon University
AI-Driven Hip Exoskeleton Control for Diverse Users and Walking TasksNCT07940127Not applicableHealthy Volunteers, Gait …University of Texas at AustinAustinNov 16Recruiting
+ 4 more sites in this state in the full list

Showing 12 of 51 US recruiting sites. We don't yet claim a study changed status or added a site this week; those checks start once weekly snapshots can be compared.

Data from ClinicalTrials.gov, a U.S. government database. Registry data timestamp: Nov 20, 2026, 10:00:05 (as published; the field has no time zone). Processed: Nov 20, 2026, 12:54 PM ET. EnrollFeed is not affiliated with or endorsed by ClinicalTrials.gov, NLM or NIH. Sponsors and investigators are responsible for each record; check the NCT link for the current version.

Simple monthly pricing

No free tier. We charge for curation, timing and delivery, not for the ClinicalTrials.gov records. Cancel by replying to the email or your receipt.

Individual

$149/mo

One recipient.

  • The weekly list, every Monday by 8am ET or a weekday you choose
  • Grouped by state and lead sponsor, with a link to each NCT record
  • Data timestamp and processing date on every issue
Subscribe — $149/mo

Checkout opens once terms are final

Team

$299/mo

Up to 3 people at one organization.

  • Everything in Individual
  • Up to 3 recipients
Subscribe — Team

Checkout opens once terms are final

Free one-week sample by reply. Email hello@enrollfeed.com with the states and therapy areas you cover.

Questions

What is in the digest?

Studies first posted on ClinicalTrials.gov in the past week that are currently recruiting and have at least one US recruiting site, with facility, city, state, phase, conditions, sponsor and a link to the study record.

Does “newly posted” mean the study just started recruiting or added a site?

No. It means the study record was first posted in the past week and is now recruiting. Status changes and new sites will be listed only after we can compare weekly snapshots.

Where does the data come from?

ClinicalTrials.gov, a U.S. government database. The sponsor or investigator is responsible for the accuracy of each record. This product is not affiliated with or endorsed by NIH, NLM, or ClinicalTrials.gov.

Do you include investigator or site contact details?

No. We do not include names, phone numbers or email addresses from the study records.

When is it delivered?

Every Monday by 8am ET by default, or on another weekday you choose.

How much does it cost?

$149 per month. There is no free tier. You can ask for a free one-week sample by emailing hello@enrollfeed.com.